Evotec
Aglaia Kakoulidou is a Senior Research Assistant at Evotec since November 2017, with experience in conducting and documenting experiments and communicating key findings to stakeholders. Previous roles include a Bioinformatics intern at Oak Bioinformatics LLC, where Aglaia incorporated cancer hotspots into platform modules and created SQLite databases, as well as a Master's thesis on microglial proliferation at Universitat Autònoma de Barcelona, achieving a grade of 9/10. Earlier academic work includes a Bachelor's thesis on the gene of transcription factor ZNF577, earning a grade of 10/10 at Ethnikon kai Kapodistriakon Panepistimion Athinon, along with experience as a Chemistry Teacher at Municipality School of Pallini. Educational qualifications include a Master’s Degree in Neurosciences and a course in Computer Optimized Microscopy with a focus on Image Analysis.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.